Guanjie Yang

Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy

Chang-cheng Guo, Bin Yang, B. Peng, 2022, Frontiers in Oncology.

Re: Karim A. Touijer, Daniel D. Sjoberg, Nicole Benfante, et al. Limited Versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2021.03.006.

Bin Yang, X. Yao, Guanjie Yang, 2021, European urology oncology.

Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer

Chang-cheng Guo, Bin Yang, B. Peng, 2022, Frontiers in Oncology.

Perioperative change of circulating tumor cells in cytoreductive radical prostatectomy for oligometastatic hormone-sensitive prostate cancer: the preliminary safety evidence from long-term oncologic outcomes

Chang-cheng Guo, Bin Yang, X. Yao, 2023, International Urology and Nephrology.

Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.

Zhengquan Yu, Minjia Tan, B. Dong, 2023, Cancer cell.

Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer

Ruiliang Wang, Guanjie Yang, Jun Xie, 2024, iScience.

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer

Hongliang Fu, Ruiliang Wang, Hanxu Guo, 2023, Cancer research communications.

Autologous endothelial progenitor cells and bioactive factors improve bladder regeneration.

Liuhua Zhou, Feng Zhao, Guanjie Yang, 2023, Tissue engineering. Part C, Methods.